Endocrinology

Top Story

DAPA-HF: Dapagliflozin’s HF benefits consistent regardless of age, symptom severity

DAPA-HF: Dapagliflozin’s HF benefits consistent regardless of age, symptom severity
November 17, 2019

Read the Perspective from Richard E. Pratley, MD

Meeting NewsPerspective

Dapagliflozin confers consistent benefit in HF without diabetes: DAPA-HF

November 16, 2019
PHILADELPHIA — New analyses of the DAPA-HF trial suggest that the benefits of the SGLT2 inhibitor dapagliflozin extend beyond its effects as a type 2 diabetes…

NIH selects five Lasker Clinical Research Scholars

November 16, 2019
The NIH selected five scientists as Lasker Clinical Research Scholars. The competitive program — part of a joint initiative with Albert and Mary Lasker Foundation…
In the Journals

Levothyroxine neutral for bone health in subclinical hypothyroidism

November 15, 2019
Older adults with subclinical hypothyroidism assigned 1 year of levothyroxine therapy experienced no adverse changes in any bone parameters compared with similar adults…
In the Journals

Cabergoline may increase recurrence risk after remission in Cushing’s disease

November 15, 2019
Use of the dopamine agonist cabergoline during conventional fractionated radiotherapy to treat Cushing’s disease may be associated with a higher disease recurrence…
More Headlines »
CME ABIM MOC

Best of Obesity Forum® 2018

This activity is supported by an educational grant from Novo Nordisk, Inc.

The incidence of obesity has increased dramatically over the past 20 years and is considered to be an epidemic in the…
More »
Video
Meeting News

VIDEO: Bariatric surgery can address severe obesity epidemic

October 31, 2019
More »
Resource Centers
ObesityWeek

ObesityWeek

CME ABIM MOC

Ace the Case: A 65-Year-Old Patient with Longstanding History of Type 2 Diabetes (T2DM)

No commercial support for this activity.

This educational activity will use a case study to discuss the use of follow-on insulins in a 65-year-old male with…
More »
Current Issues
View the Current Issue